No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Acyltransferases / antagonists & inhibitors
-
Acyltransferases / genetics
-
Adult
-
Aged
-
Female
-
Homozygote*
-
Humans
-
Liver / drug effects
-
Liver / pathology
-
Male
-
Middle Aged
-
Mutation
-
Non-alcoholic Fatty Liver Disease* / drug therapy
-
Non-alcoholic Fatty Liver Disease* / genetics
-
Non-alcoholic Fatty Liver Disease* / metabolism
-
Non-alcoholic Fatty Liver Disease* / pathology
-
Phospholipases A2, Calcium-Independent / antagonists & inhibitors
-
Phospholipases A2, Calcium-Independent / genetics
-
Polymorphism, Single Nucleotide
-
Precision Medicine / methods
-
Proof of Concept Study
-
RNA, Small Interfering* / administration & dosage
-
RNA, Small Interfering* / adverse effects
-
RNA, Small Interfering* / pharmacokinetics
-
Young Adult
Substances
-
Acyltransferases
-
Phospholipases A2, Calcium-Independent
-
PNPLA3 protein, human
-
RNA, Small Interfering